Tuesday, April 28, 2026

Chinese Robot Vacuums Now Speak Siri and SmartThings

Chinese robot vacuum companies like Roborock and Ecovacs are entering the domestic appliance ecosystem with the Matter standard.

Hyundai’s Bold Move: How AI and Robotics Will Transform the Future of EVs by 2028

Hyundai's CEO announces plans for AI transformation, autonomous driving, and expanded global production to enhance competitiveness.

What to Expect from Kim Min-seok’s 75-Minute Press Conference: Trade, Politics, and More

Prime Minister Kim Min-seok's upcoming press conference will address U.S. visit outcomes, tariffs, and his political ambitions for leadership.

Tag: ALT-B4

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us